ArticleFrontiers in endocrinology2025
Association of neutrophil to high-density lipoprotein cholesterol ratio with overactive bladder: a population-based study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Inflammation is involved in the progression of overactive bladder (OAB). This study aimed to investigate the association between the neutrophil to high-density lipoprotein cholesterol ratio (NHR) and OAB. Methods: Data from seven cycles of the National Health and Nutrition Examination Survey (NHANES) from 2005 to 2018 were analyzed to examine the relationship between NHR and OAB. Multivariable logistic regression model was used to estimate the association between NHR and OAB, along with restricted cubic spline regression to assess the dose-response relationship. Additionally, subgroup analyses were conducted. Results: Among 29,315 participants, 5,815 had OAB. After covariate adjustment, we found that NHR was positively associated with the odds of OAB. Notably, the relationship between NHR and OAB was nonlinear. There was a threshold at NHR = 2.85. When NHR < 2.85, no significant association was observed; when NHR ≥ 2.85, a positive association emerged. Subgroup and interaction analyses further revealed that the link between NHR and OAB was stronger in obese participants. Conclusion: Our results indicate a nonlinear association between NHR and OAB. When NHR is ≥ 2.85, there is a strong positive association between NHR and the odds of OAB. The interaction between obesity and NHR further increases the prevalence of OAB. Prospective and multicenter studies are needed in the future to elucidate the potential mechanism underlying the association between NHR and OAB and determine the causal relationship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.